Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ultrabright Biotech is a Munich-based life science company specializing in next-generation signal amplification for molecular diagnostics. A spin-out from Plectonic Biotech, the company leverages over 15 years of expertise in DNA-nanotechnology to develop its proprietary "Ultra Beacons" platform. These beacons are highly amplified antibody labels that deliver up to 100x brighter signals with low background, enabling the detection of rare biomarkers and low-expressing cellular targets that are often beyond the limits of traditional assays. The technology integrates seamlessly into existing workflows such as flow cytometry, immunoassays, and liquid biopsy, providing researchers and clinicians with unprecedented sensitivity and clarity for diagnostic and research applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ultra Brite.